Early visual impacts of optical coherence tomographic parameters in patients with age-related macular degeneration following the first versus repeated ranibizumab injection

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 249, Issue 10, 2011, Pages 1449-1458

  Sayed, Khulood Mohammed ^a,b   Naito, Takeshi ^a   Nagasawa, Toshihiko ^a   Katome, Takashi ^a   Mitamura, Yoshinori ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b Sohag University   (Egypt)

Author keywords

Age related macular degeneration; Optical coherence tomography; Ranibizumab

Indexed keywords

GATIFLOXACIN; RANIBIZUMAB; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PHOTODYNAMIC THERAPY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PSEUDOPHAKIA; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RETINA FOVEA; RETINA MACULA AGE RELATED DEGENERATION; RETROSPECTIVE STUDY; VISION; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, HUMANIZED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAVITREAL INJECTIONS; MACULAR DEGENERATION; MALE; MIDDLE AGED; RETINA; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 80755175715     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-011-1672-2     Document Type: Article

References (30)

1. NM Bressler SB Bressler NG Congdon FL Ferris 3rd DS Friedman R Klein AS Lindblad RC Milton JM Seddon 2003 Potential public health impact of age-related eye disease study results: AREDS Report No. 11 Arch Ophthalmol 121 1621 1624 14609922 10.1001/archopht.121.11.1621 (Pubitemid 37392370)
2. MM Brown GC Brown S Sharma JD Stein Z Roth J Campanella GR Beauchamp 2006 The burden of age-related macular degeneration: a value-based analysis Curr Opin Ophthalmol 17 257 266 16794438 (Pubitemid 44309749)
3. HA Kahn HM Leibowitz JP Ganley MM Kini T Colton RS Nickerson TR Dawber 1977 The Framingham Eye Study I. Outline and major prevalence findings Am J Epidemiol 106 17 32 879158 1:STN:280:DyaE2s3hvFWksQ%3D%3D (Pubitemid 8160455)
4. FL Ferris III SL Fine L Hyman 1984 Age-related macular degeneration and blindness due to neovascular maculopathy Arch Ophthalmol 102 1640 1642 6208888 (Pubitemid 15204559)
5. K Sayanagi S Sharma T Yamamoto PK Kaiser 2009 Comparison of spectral-domain versus time-domain optical coherence tomography in management of age-related macular degeneration with ranibizumab Ophthalmology 116 947 955 19232732 10.1016/j.ophtha.2008.11.002
6. PF Lopez BD Sippy HM Lambert AB Thach DR Hinton 1996 Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes Invest Ophthalmol Vis Sci 37 855 868 8603870 1:STN:280:DyaK287otFCnsQ%3D%3D
7. MS Ip IU Scott GC Brown MM Brown AC Ho SS Huang FM Recchia 2008 Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration: a report by the American Academy of Ophthalmology Ophthalmology 115 10 1837 1846 18929163 10.1016/j.ophtha.2008.08.012
8. PK Kaiser BA Blodi H Shapiro NR Acharya 2007 Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration Ophthalmology 114 10 1868 1875 17628683 10.1016/j.ophtha.2007.04.030 (Pubitemid 47483925)
9. J Mordenti RA Cuthbertson N Ferrara K Thomsen L Berleau V Licko PC Allen CR Valverde YG Meng DT Fei KM Fourre AM Ryan 1999 Comparisons of the intraocular tissue distribution, pharmacokinetics, and safety of 125I-labeled full-length and Fab antibodies in rhesus monkeys following intravitreal administration Toxicol Pathol 27 536 544 10528633 10.1177/019262339902700507 1:CAS:528:DyaK1MXmsFyntLo%3D (Pubitemid 29446822)
10. Y Chen C Wiesmann G Fuh B Li HW Christinger P McKay AM de Vos HB Lowman 1999 Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen J Mol Biol 293 865 881 10543973 10.1006/jmbi.1999.3192 1:CAS:528:DyaK1MXmvFOnsbs%3D (Pubitemid 29527672)
11. KA Houck DW Leung AM Rowland J Winer N Ferrara 1992 Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms J Biol Chem 267 26031 26037 1464614 1:CAS:528:DyaK38Xmt1OjsL8%3D (Pubitemid 23014012)
12. A Van de Moere SS Sandhu SJ Talks 2006 Correlation of optical coherence tomography and fundus fluorescein angiography following photodynamic therapy for choroidal neovascular membrane Br J Ophthalmol 90 304 306 16488950 10.1136/bjo.2005.079947 (Pubitemid 43325460)
13. N Eter RF Spaide 2005 Comparison of fluorescein angiography and optical coherence tomography for patients with choroidal neovascularization after photodynamic therapy Retina 25 691 696 16141855 10.1097/00006982-200509000-00002 (Pubitemid 41254537)
14. MV Emerson AK Lauer CJ Flaxel DJ Wilson PJ Francis JT Stout GG Emerson TK Schlesinger SK Nolte ML Klein 2007 Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration Retina 27 439 444 17420695 10.1097/IAE.0b013e31804b3e15 (Pubitemid 46624283)
15. H Hayashi K Yamashiro A Tsujikawa M Ota A Otani N Yoshimura 2009 Association between foveal photoreceptor integrity and visual outcome in neovascular age-related macular degeneration Am J Ophthalmol 148 1 83 89 19327745 10.1016/j.ajo.2009.01.017
16. T Moutray M Alarbi G Mahon M Stevenson U Chakravarthy 2008 Relationships between clinical measures of visual function, fluorescein angiographic and optical coherence tomography features in patients with subfoveal choroidal neovascularisation Br J Ophthalmol 92 3 361 364 18303157 10.1136/bjo.2007.123976 1:STN:280:DC%2BD1c7ktlOgtA%3D%3D (Pubitemid 351363531)
17. PA Keane S Liakopoulos KT Chang M Wang L Dustin AC Walsh SR Sadda 2008 Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration Ophthalmology 115 12 2206 2214 18930551 10.1016/j.ophtha.2008.08.016
18. A Oishi M Hata M Shimozono M Mandai A Nishida Y Kurimoto 2010 The significance of external limiting membrane status for visual acuity in age-related macular degeneration Am J Ophthalmol 150 27 32 20609705 10.1016/j.ajo.2010.02.012
19. PJ Rosenfeld DM Brown JS Heier DS Boyer PK Kaiser CY Chung RY Kim 2006 Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 1419 1431 17021318 10.1056/NEJMoa054481 1:CAS:528:DC%2BD28XhtVGgtr3M (Pubitemid 44511557)
20. AJ Augustin S Puls I Offermann 2007 Triple therapy for choroidal neovascularization due to age-related macular degeneration: verteporfin PDT, bevacizumab, and dexamethasone Retina 27 133 140 17290193 10.1097/IAE. 0b013e3180323de7
21. I Krebs S Binder U Stolba K Schmid C Glittenberg W Brannath A Goll 2005 Optical coherence tomography guided retreatment of photodynamic therapy Br J Ophthalmol 89 1184 1187 16113378 10.1136/bjo.2005.067389 1:STN:280: DC%2BD2MvksFWlsw%3D%3D (Pubitemid 41224472)
22. J Sahni P Stanga D Wong S Harding 2005 Optical coherence tomography in photodynamic therapy for subfoveal choroidal neovascularisation secondary to age related macular degeneration: a cross-sectional study Br J Ophthalmol 89 316 320 15722312 10.1136/bjo.2004.043364 1:STN:280:DC%2BD2M7hs1Onuw%3D%3D (Pubitemid 40327616)
23. PA Keane S Liakopoulos SC Ongchin FM Heussen S Msutta KT Chang AC Walsh SR Sadda 2008 Quantitative subanalysis of optical coherence tomography after treatment with ranibizumab for neovascular age-related macular degeneration Invest Ophthalmol Vis Sci 49 7 3115 3120 18408176 10.1167/iovs.08-1689
24. AJ Witkin LN Vuong VJ Srinivasan I Gorczynska E Reichel CR Baumal AH Rogers JS Schuman JG Fujimoto JS Duker 2009 High-speed ultrahigh resolution optical coherence tomography before and after ranibizumab for age-related macular degeneration Ophthalmology 116 5 956 963 19410953 10.1016/j.ophtha.2008. 12.018
25. CG Kiss W Geitzenauer C Simader G Gregori U Schmidt-Erfurth 2009 Evaluation of ranibizumab-induced changes in high-resolution optical coherence tomographic retinal morphology and their impact on visual function Invest Ophthalmol Vis Sci 50 5 2376 2383 19136707 10.1167/iovs.08-2017
26. O Strauss 2005 The retinal pigment epithelium in visual function Physiol Rev 85 845 881 15987797 10.1152/physrev.00021.2004 1:CAS:528: DC%2BD2MXmsFymu7Y%3D (Pubitemid 40885218)
27. CG Kiss T Barisani-Asenbauer C Simader S Maca U Schmidt-Erfurth 2008 Central visual field impairment during and following cystoid macular oedema Br J Ophthalmol 92 84 88 17591669 10.1136/bjo.2007.124016 1:STN:280: DC%2BD2sjlvF2jug%3D%3D
28. E Midena S Vujosevic E Convento A Manfre F Cavarzeran E Pilotto 2007 Microperimetry and fundus autofluorescence in patients with early age-related macular degeneration Br J Ophthalmol 91 1499 1503 17504849 10.1136/bjo.2007. 119685 (Pubitemid 350044055)
29. TH Tezel LV Del Priore BE Flowers DH Grosof IL Benenson RL Zamora HJ Kaplan 1996 Correlation between scanning laser ophthalmoscope microperimetry and anatomic abnormalities in patients with subfoveal neovascularization Ophthalmology 103 1829 1836 8942878 1:STN:280:DyaK2s%2FpvVegtQ%3D%3D (Pubitemid 26403736)
30. U Schneider W Inhoffen F Gelisken I Kreissig 1996 Assessment of visual function in choroidal neovascularization with scanning laser microperimetry and simultaneous indocyanine green angiography Graefes Arch Clin Exp Ophthalmol 234 612 617 8897052 10.1007/BF00185293 1:STN:280:DyaK2s%2Flt1Ciug%3D%3D (Pubitemid 26340603)